You searched for:

13613 results

Clinical Commissioning Policy: Everolimus for refractory focal onset seizures associated with tuberous sclerosis complex (ages 2 years and above)

This policy document outlines the arrangements for funding of treatment for refractory focal onset seizures, associated with tuberous sclerosis complex, for ages 2 years and above.

Service specification: DNA Nucleotide Excision Repair Disorders Service (all ages)

This service specification outlines the provision of a single, nationally integrated, multidisciplinary clinical and molecular diagnostic service to co-ordinate the care and management of patients with DNA nucleotide excision repair disorders.

Clinical commissioning policy: Bendamustine with rituximab for first line treatment of advanced indolent non-Hodgkin’s lymphoma (all ages)

This policy document outlines the arrangements for funding of treatment for first line treatment of advanced indolent non-Hodgkin’s lymphoma.